BridgeBio Pharma, Inc (BBIO) insider trading
Every open-market stock purchase and sale by BridgeBio Pharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $98.1M over the last 12 months (34 sales). No open-market buys.
- Last insider buy: Andrea Ellis (Director), $101K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $98.1M (34 sales). Last close $67.61 on Jun 4, 2026.
Recent BBIO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | Jennifer E. Cook (Director) | Sold | $2.6M |
| Jun 24, 2026 | Jennifer E. Cook (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Jennifer E. Cook (Director) | Bought (not open market) | — |
| Jun 23, 2026 | Jennifer E. Cook (Director) | Sold | $151K |
| Jun 23, 2026 | Hannah Valantine (Director) | Sold | $151K |
| Jun 22, 2026 | Hannah Valantine (Director) | Sold | $191K |
| Jun 22, 2026 | Hannah Valantine (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Eric Aguiar (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Charles J Homcy (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Andrea Ellis (Director) | Bought (not open market) | — |
| Jun 22, 2026 | James C Momtazee (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Douglas A. Dachille (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Hannah Valantine (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Hannah Valantine (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Frank McCormick (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Charles J Homcy (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Jennifer E. Cook (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Ali J. Satvat (Director) | Bought (not open market) | — |
| Jun 22, 2026 | James C Momtazee (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Douglas A. Dachille (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Fred Hassan (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Fred Hassan (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Andrew Lo (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Ronald J Daniels (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Andrea Ellis (Director) | Bought (not open market) | — |
Who's trading BBIO
- Jennifer E. Cook, Director: sold $8.8M (4 sales), last Jun 24, 2026
- Hannah Valantine, Director: sold $4.4M (6 sales), last Jun 23, 2026
- Douglas A. Dachille, Insider: other filings, last Jun 22, 2026
- Andrea Ellis, Insider: sold $4.2M (1 sale), last Jun 22, 2026
- Charles J Homcy, Insider: other filings, last Jun 22, 2026
- Fred Hassan, Insider: other filings, last Jun 22, 2026
- Eric Aguiar, Insider: other filings, last Jun 22, 2026
- Ronald J Daniels, Director: sold $3.9M (1 sale), last Jun 22, 2026
- Andrew Lo, Director: sold $6.3M (4 sales), last Jun 22, 2026
- Frank McCormick, Director: sold $13.3M (6 sales), last Jun 22, 2026
- James C Momtazee, Insider: other filings, last Jun 22, 2026
- Ali J. Satvat, Insider: other filings, last Jun 22, 2026
- Neil Kumar, CEO: sold $51.6M (99 sales), last Jun 5, 2026
- Thomas Trimarchi, CFO: sold $3M (6 sales), last May 18, 2026
- Maricel Apuli, C-suite exec: sold $462K (4 sales), last May 16, 2026
Get free alerts when an insider at BridgeBio Pharma, Inc files a new trade →